Matches in Library of Congress for { <http://lccn.loc.gov/2012015100> ?p ?o. }
Showing items 1 to 25 of
25
with 100 items per page.
- 2012015100 contributor B12444529.
- 2012015100 created "c2013.".
- 2012015100 date "2013".
- 2012015100 date "c2013.".
- 2012015100 dateCopyrighted "c2013.".
- 2012015100 description "Includes bibliographical references and index.".
- 2012015100 description "Issues and perspectives on patenting of biologics -- Biologic patent law in the U.S. -- Biologic patenting beyond the U.S. -- Philosophy of patenting of biologics -- Economics of patenting of biologics -- The origins of regulation of biologics as drugs -- Understanding how biologics are regulated in the U.S. --Regulatory authority and organizations in the U.S. -- Types of biologics and associated regulatory approaches : human cells, tissues, and cellular and tissue-based products -- Blood and blood components -- General requirements for biologic products : vaccines, viruses, and spores -- Drugs -- Gene therapy and cellular therapy -- WJS February 28, 2012 -- Human organs for transplantation -- Xenotransplantation -- Combination products -- Stem cells -- Emerging issues in biologic regulation -- Fundamentals of biologic discovery and production and issues in making and using biosimilar biologics -- Small molecules, energy, and biosynthesis -- Macromolecules -- Protein function -- Basic genetic mechanisms.".
- 2012015100 extent "p. cm.".
- 2012015100 identifier "9781617460081 (alk. paper)".
- 2012015100 issued "2013".
- 2012015100 issued "c2013.".
- 2012015100 language "eng".
- 2012015100 publisher "Arlington, VA : Bloomberg BNA,".
- 2012015100 spatial "United States".
- 2012015100 spatial "United States.".
- 2012015100 subject "346.7304/86 23".
- 2012015100 subject "Biotechnology Patents.".
- 2012015100 subject "Biotechnology United States Patents.".
- 2012015100 subject "Drugs Patents.".
- 2012015100 subject "Drugs United States Patents.".
- 2012015100 subject "KF3133.D78 B56 2013".
- 2012015100 subject "Patent laws and legislation United States.".
- 2012015100 tableOfContents "Issues and perspectives on patenting of biologics -- Biologic patent law in the U.S. -- Biologic patenting beyond the U.S. -- Philosophy of patenting of biologics -- Economics of patenting of biologics -- The origins of regulation of biologics as drugs -- Understanding how biologics are regulated in the U.S. --Regulatory authority and organizations in the U.S. -- Types of biologics and associated regulatory approaches : human cells, tissues, and cellular and tissue-based products -- Blood and blood components -- General requirements for biologic products : vaccines, viruses, and spores -- Drugs -- Gene therapy and cellular therapy -- WJS February 28, 2012 -- Human organs for transplantation -- Xenotransplantation -- Combination products -- Stem cells -- Emerging issues in biologic regulation -- Fundamentals of biologic discovery and production and issues in making and using biosimilar biologics -- Small molecules, energy, and biosynthesis -- Macromolecules -- Protein function -- Basic genetic mechanisms.".
- 2012015100 title "Biologic patent law and regulation / William J. Simmons, editor-in-chief.".
- 2012015100 type "text".